A detailed history of Imz Advisory Inc transactions in Eli Lilly & CO stock. As of the latest transaction made, Imz Advisory Inc holds 649 shares of LLY stock, worth $574,975. This represents 0.29% of its overall portfolio holdings.

Number of Shares
649
Previous 648 0.15%
Holding current value
$574,975
Previous $504 Million 16.56%
% of portfolio
0.29%
Previous 0.26%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 12, 2024

BUY
$724.87 - $909.04 $724 - $909
1 Added 0.15%
649 $587 Million
Q1 2024

Apr 15, 2024

BUY
$592.2 - $792.28 $1,184 - $1,584
2 Added 0.31%
648 $504 Million
Q4 2023

Apr 02, 2024

BUY
$525.19 - $619.13 $339,272 - $399,957
646 New
646 $506 Million

Others Institutions Holding LLY

About ELI LILLY & Co


  • Ticker LLY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 950,174,976
  • Market Cap $842B
  • Description
  • Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...
More about LLY
Track This Portfolio

Track Imz Advisory Inc Portfolio

Follow Imz Advisory Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Imz Advisory Inc, based on Form 13F filings with the SEC.

News

Stay updated on Imz Advisory Inc with notifications on news.